[The expression of integrinανβ6 and MMP-9 in gastric cancer and the correlation with clinicopathologic characteristic].
to investigate the expression of integrinανβ6 and MMP-9 in gastric cancer and the correlation with clinicopathologic characteristic. the expression of integrinανβ6 and MMP-9 protein was detected with immunohistochemical EnVision plus non-hiotin technique in 94 cases of gastric cancer and pericarcinoma tissues. The correlation with clinicopathologic characteristic were analyzed. the positive expression rates of integrinανβ6 and MMP-9 protein in gastric cancer were significantly higher that tat in pericarcinoma tissues (P<0.01). The expression of integrinανβ6 were positively related to Lauren type, tumor clinical stage, differentiation degree and lymph node metascasis (N stage) (P<0.01). The expression of MMP-9 were positively related Lauren type, tumor clinical stage, differentiation degree, depth of invasion and lymph node metascasis (N stage)(P<0.01). The expression of integrinανβ6 was positively correlated with MMP-9 (r=0.672, P<0.01). Trough Cox multivariate regression analysis, Lauren type, lymph node metascasis (N stage), the expression of integrinανβ6 and MMP-9 showed significant associations with 5-year survival rate. the overexpression of integrinανβ6 and MMP-9 in gastric cancer is closely correlated with tumor invasion and metastasis. They may be as prognostic markers and target proteins.